Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Sanofi
Surya P Bhatt; Klaus F Rabe; Nicola A Hanania; Claus F Vogelmeier; Jeremy Cole; Mona Bafadhel; Stephanie A Christenson; Alberto Papi; Dave Singh; Elizabeth Laws; Leda P Mannent; Naimish Patel; Heribert W Staudinger; George D Yancopoulos; Eric R Mortensen; Bolanle Akinlade; Jennifer Maloney; Xin Lu; Deborah Bauer; Ashish Bansal; Lacey B Robinson; Raolat M Abdulai; BOREAS Investigators